Recent Posts

Now in press & online @ Ophthalmology, the journal of the American Academy of Op…

Now in press & online @ Ophthalmology, the journal of the American Academy of Ophthalmology, the first phase 3 trial to evaluate suprachoroidal injection for treatment of an ocular disease… https://t.co/hgCc9WHHdu Source by Thomas Ciulla, MD, MBA Return to main website.

Disruption brings harmony in biotech: The rise of anti-VEGF therapy shows what i…

Disruption brings harmony in biotech: The rise of anti-VEGF therapy shows what industry, academia, private practice can create together. https://t.co/WwBCk4kkr8 Source by Thomas Ciulla, MD, MBA Return to main website.

RT @OphthalmicPro: Are you curious about gene therapy? Check out Dr. Thomas Ciul…


RT @OphthalmicPro: Are you curious about gene therapy? Check out Dr. Thomas Ciulla’s article at https://t.co/82jHtEhRGq #ophthalmology #eye…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @RetinalPhys: Clearside Biomedical said it has done significant preclinical t…

RT @RetinalPhys: Clearside Biomedical said it has done significant preclinical testing of the anti-VEGF axitinib and plans to begin a clini… Source by Thomas Ciulla, MD, MBA Return to main website.

In San Francisco this week for the JP Morgan Healthcare Conference #jpm2020. Lo…

In San Francisco this week for the JP Morgan Healthcare Conference #jpm2020. Looking forward to connecting with old friends and colleagues. Please reach out if you want to catch up. Source by Thomas Ciulla, MD, MBA Return to main website.

RT @OphthalmicPro: Gene therapy has gotten some major buzz in the medical commun…


RT @OphthalmicPro: Gene therapy has gotten some major buzz in the medical community of late. In this issue, Dr. Thomas Ciulla gives us a pr…


Source by Thomas Ciulla, MD, MBA

Return to main website.

Vascular alterations in macular degeneration and diabetic retinopathy, reviewed …

Vascular alterations in macular degeneration and diabetic retinopathy, reviewed in this chapter we just published…. https://t.co/X0OzpZAMga Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinalPhys: NEW PRODUCT APPLICATIONS: Data Analytics Give Retinal Physician…

RT @RetinalPhys: NEW PRODUCT APPLICATIONS: Data Analytics Give Retinal Physicians an Edge: Designed for these users, analytics provide insi… Source by Thomas Ciulla, MD, MBA Return to main website.

Just co-authored this paper…Despite new therapies for AMD, the leading causing…


Just co-authored this paper…Despite new therapies for AMD, the leading causing of vision loss, treatment burden and limited outcomes persist…

https://t.co/onrebZdz0q https://t.co/oXoIsnL6rk


Source by Thomas Ciulla, MD, MBA

Return to main website.

Recently published this chapter on Vitreous Pathology, which contributes to vit…

Recently published this chapter on Vitreous Pathology, which contributes to vitreomacular traction, macular hole & pucker, retinal detachment, & macular edema. Vitreous has a role in proliferative diabetic retinopathy.. https://t.co/mkfqrPCoHl Source by Thomas Ciulla, MD, MBA Return to main website.